These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 11753685)
1. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit. Neary CL; Cho-Chung YS Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685 [TBL] [Abstract][Full Text] [Related]
2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein. Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726 [TBL] [Abstract][Full Text] [Related]
3. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy. Cho YS; Cho-Chung YS Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683 [TBL] [Abstract][Full Text] [Related]
5. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Nesterova MV; Cho-Chung YS Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis. Nesterova MV; Cho-Chung YS Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142 [TBL] [Abstract][Full Text] [Related]
7. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy. Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938 [TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit. Nesterova M; Cho-Chung YS Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. Alper O; Hacker NF; Cho-Chung YS Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835 [TBL] [Abstract][Full Text] [Related]
11. Patterns of cyclic AMP-dependent protein kinase gene expression during ontogeny of the murine palate. Greene RM; Lloyd MR; Uberti M; Nugent P; Pisano MM J Cell Physiol; 1995 Jun; 163(3):431-40. PubMed ID: 7775586 [TBL] [Abstract][Full Text] [Related]
12. Ethanol-induced translocation of protein kinase A occurs in two phases: control by different molecular mechanisms. Dohrman DP; Chen HM; Gordon AS; Diamond I Alcohol Clin Exp Res; 2002 Mar; 26(3):407-15. PubMed ID: 11923596 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion. Neary CL; Nesterova M; Cho YS; Cheadle C; Becker KG; Cho-Chung YS Oncogene; 2004 Nov; 23(54):8847-56. PubMed ID: 15480415 [TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207 [TBL] [Abstract][Full Text] [Related]
15. The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Tortora G; Pepe S; Bianco C; Baldassarre G; Budillon A; Clair T; Cho-Chung YS; Bianco AR; Ciardiello F Oncogene; 1994 Nov; 9(11):3233-40. PubMed ID: 7936647 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cAMP-dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells. Boundy VA; Chen J; Nestler EJ J Pharmacol Exp Ther; 1998 Aug; 286(2):1058-65. PubMed ID: 9694969 [TBL] [Abstract][Full Text] [Related]
17. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines. Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748 [TBL] [Abstract][Full Text] [Related]
18. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS). Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976 [TBL] [Abstract][Full Text] [Related]
19. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer. Cvijic ME; Kita T; Shih W; DiPaola RS; Chin KV Clin Cancer Res; 2000 Jun; 6(6):2309-17. PubMed ID: 10873081 [TBL] [Abstract][Full Text] [Related]
20. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP. Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]